Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Developmental Biology R-HSA-1266738
PTK6 Regulates Cell Cycle R-HSA-8849470
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
RMTs methylate histone arginines R-HSA-3214858
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Meiotic recombination R-HSA-912446
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Cellular responses to stimuli R-HSA-8953897
G1/S Transition R-HSA-69206
Disease R-HSA-1643685
Cell Cycle, Mitotic R-HSA-69278
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Transcriptional regulation of granulopoiesis R-HSA-9616222
Chromatin modifying enzymes R-HSA-3247509
Cell Cycle R-HSA-1640170
Cyclin E associated events during G1/S transition R-HSA-69202
Signal Transduction R-HSA-162582
G1 Phase R-HSA-69236
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Diseases of cellular response to stress R-HSA-9675132
Cellular responses to stress R-HSA-2262752
Oncogene Induced Senescence R-HSA-2559585
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Reproduction R-HSA-1474165
Diseases of mitotic cell cycle R-HSA-9675126
S Phase R-HSA-69242
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
RNA Polymerase II Transcription R-HSA-73857
Chromatin organization R-HSA-4839726
Diseases of Cellular Senescence R-HSA-9630747
Cyclin D associated events in G1 R-HSA-69231
Signaling by PTK6 R-HSA-8848021
Meiosis R-HSA-1500620
Oxidative Stress Induced Senescence R-HSA-2559580
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Cellular Senescence R-HSA-2559583
Generic Transcription Pathway R-HSA-212436
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Transcriptional regulation by RUNX2 R-HSA-8878166
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Gene expression (Transcription) R-HSA-74160
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Mitotic G1 phase and G1/S transition R-HSA-453279
Transcriptional regulation by RUNX2 R-HSA-8878166
Diseases of mitotic cell cycle R-HSA-9675126
Signal Transduction R-HSA-162582
Cyclin E associated events during G1/S transition R-HSA-69202
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
G1 Phase R-HSA-69236
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Cellular responses to stimuli R-HSA-8953897
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Cell Cycle, Mitotic R-HSA-69278
Signaling by PTK6 R-HSA-8848021
Cell Cycle R-HSA-1640170
Oxidative Stress Induced Senescence R-HSA-2559580
G1/S Transition R-HSA-69206
Generic Transcription Pathway R-HSA-212436
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Cyclin D associated events in G1 R-HSA-69231
Cellular Senescence R-HSA-2559583
Cellular responses to stress R-HSA-2262752
Developmental Biology R-HSA-1266738
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
PTK6 Regulates Cell Cycle R-HSA-8849470
Meiotic recombination R-HSA-912446
Transcriptional regulation of granulopoiesis R-HSA-9616222
Meiosis R-HSA-1500620
Mitotic G1 phase and G1/S transition R-HSA-453279
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
RMTs methylate histone arginines R-HSA-3214858
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Gene expression (Transcription) R-HSA-74160
Oncogene Induced Senescence R-HSA-2559585
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Disease R-HSA-1643685
S Phase R-HSA-69242
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Chromatin modifying enzymes R-HSA-3247509
Diseases of Cellular Senescence R-HSA-9630747
Chromatin organization R-HSA-4839726
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
RNA Polymerase II Transcription R-HSA-73857
Reproduction R-HSA-1474165
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Diseases of cellular response to stress R-HSA-9675132
Oxidative Stress Induced Senescence R-HSA-2559580
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Diseases of mitotic cell cycle R-HSA-9675126
Mitotic G1 phase and G1/S transition R-HSA-453279
Generic Transcription Pathway R-HSA-212436
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Disease R-HSA-1643685
Chromatin modifying enzymes R-HSA-3247509
Cyclin E associated events during G1/S transition R-HSA-69202
PTK6 Regulates Cell Cycle R-HSA-8849470
G1/S Transition R-HSA-69206
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Cellular Senescence R-HSA-2559583
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Transcriptional regulation by RUNX2 R-HSA-8878166
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Chromatin organization R-HSA-4839726
Signal Transduction R-HSA-162582
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
Diseases of cellular response to stress R-HSA-9675132
RMTs methylate histone arginines R-HSA-3214858
G1 Phase R-HSA-69236
Meiosis R-HSA-1500620
RNA Polymerase II Transcription R-HSA-73857
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Gene expression (Transcription) R-HSA-74160
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Signaling by PTK6 R-HSA-8848021
Cellular responses to stimuli R-HSA-8953897
Developmental Biology R-HSA-1266738
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
Meiotic recombination R-HSA-912446
Reproduction R-HSA-1474165
Cyclin D associated events in G1 R-HSA-69231
Cell Cycle R-HSA-1640170
Transcriptional regulation of granulopoiesis R-HSA-9616222
Oncogene Induced Senescence R-HSA-2559585
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Diseases of Cellular Senescence R-HSA-9630747
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
S Phase R-HSA-69242
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Cell Cycle, Mitotic R-HSA-69278
Cellular responses to stress R-HSA-2262752
Reproduction R-HSA-1474165
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
Gene expression (Transcription) R-HSA-74160
Diseases of mitotic cell cycle R-HSA-9675126
Mitotic G1 phase and G1/S transition R-HSA-453279
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
PTK6 Regulates Cell Cycle R-HSA-8849470
Signal Transduction R-HSA-162582
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Disease R-HSA-1643685
Oncogene Induced Senescence R-HSA-2559585
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Diseases of cellular response to stress R-HSA-9675132
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Diseases of Cellular Senescence R-HSA-9630747
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Chromatin organization R-HSA-4839726
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
Cyclin D associated events in G1 R-HSA-69231
Meiosis R-HSA-1500620
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Transcriptional regulation of granulopoiesis R-HSA-9616222
RNA Polymerase II Transcription R-HSA-73857
Meiotic recombination R-HSA-912446
Oxidative Stress Induced Senescence R-HSA-2559580
Cellular responses to stimuli R-HSA-8953897
G1/S Transition R-HSA-69206
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
S Phase R-HSA-69242
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
RMTs methylate histone arginines R-HSA-3214858
Cell Cycle R-HSA-1640170
G1 Phase R-HSA-69236
Cellular Senescence R-HSA-2559583
Chromatin modifying enzymes R-HSA-3247509
Transcriptional regulation by RUNX2 R-HSA-8878166
Cyclin E associated events during G1/S transition R-HSA-69202
Cell Cycle, Mitotic R-HSA-69278
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Signaling by PTK6 R-HSA-8848021
Cellular responses to stress R-HSA-2262752
Developmental Biology R-HSA-1266738
Generic Transcription Pathway R-HSA-212436
Cyclin E associated events during G1/S transition R-HSA-69202
Developmental Biology R-HSA-1266738
S Phase R-HSA-69242
Reproduction R-HSA-1474165
Cyclin D associated events in G1 R-HSA-69231
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Cell Cycle, Mitotic R-HSA-69278
Meiotic recombination R-HSA-912446
Diseases of cellular response to stress R-HSA-9675132
Transcriptional regulation of granulopoiesis R-HSA-9616222
Cellular responses to stress R-HSA-2262752
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Oncogene Induced Senescence R-HSA-2559585
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Cell Cycle R-HSA-1640170
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Diseases of Cellular Senescence R-HSA-9630747
Chromatin modifying enzymes R-HSA-3247509
Mitotic G1 phase and G1/S transition R-HSA-453279
Cellular Senescence R-HSA-2559583
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
G1 Phase R-HSA-69236
RMTs methylate histone arginines R-HSA-3214858
Signal Transduction R-HSA-162582
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
PTK6 Regulates Cell Cycle R-HSA-8849470
Transcriptional regulation by RUNX2 R-HSA-8878166
G1/S Transition R-HSA-69206
Diseases of mitotic cell cycle R-HSA-9675126
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Disease R-HSA-1643685
Generic Transcription Pathway R-HSA-212436
RNA Polymerase II Transcription R-HSA-73857
Signaling by PTK6 R-HSA-8848021
Meiosis R-HSA-1500620
Cellular responses to stimuli R-HSA-8953897
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Chromatin organization R-HSA-4839726
Oxidative Stress Induced Senescence R-HSA-2559580
Gene expression (Transcription) R-HSA-74160
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Cyclin E associated events during G1/S transition R-HSA-69202
G1/S Transition R-HSA-69206
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Cellular Senescence R-HSA-2559583
Signal Transduction R-HSA-162582
Gene expression (Transcription) R-HSA-74160
Reproduction R-HSA-1474165
Generic Transcription Pathway R-HSA-212436
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Meiosis R-HSA-1500620
Cell Cycle R-HSA-1640170
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Chromatin organization R-HSA-4839726
Cellular responses to stimuli R-HSA-8953897
G1 Phase R-HSA-69236
Diseases of mitotic cell cycle R-HSA-9675126
Diseases of cellular response to stress R-HSA-9675132
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Developmental Biology R-HSA-1266738
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Diseases of Cellular Senescence R-HSA-9630747
Cellular responses to stress R-HSA-2262752
Signaling by PTK6 R-HSA-8848021
Mitotic G1 phase and G1/S transition R-HSA-453279
Transcriptional regulation by RUNX2 R-HSA-8878166
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
Oncogene Induced Senescence R-HSA-2559585
Transcriptional regulation of granulopoiesis R-HSA-9616222
Meiotic recombination R-HSA-912446
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Disease R-HSA-1643685
Chromatin modifying enzymes R-HSA-3247509
Oxidative Stress Induced Senescence R-HSA-2559580
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Cyclin D associated events in G1 R-HSA-69231
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Cell Cycle, Mitotic R-HSA-69278
S Phase R-HSA-69242
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
PTK6 Regulates Cell Cycle R-HSA-8849470
RNA Polymerase II Transcription R-HSA-73857
RMTs methylate histone arginines R-HSA-3214858
Transcriptional regulation by RUNX2 R-HSA-8878166
G1/S Transition R-HSA-69206
Oncogene Induced Senescence R-HSA-2559585
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Gene expression (Transcription) R-HSA-74160
Mitotic G1 phase and G1/S transition R-HSA-453279
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
RMTs methylate histone arginines R-HSA-3214858
Reproduction R-HSA-1474165
Signal Transduction R-HSA-162582
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Cell Cycle, Mitotic R-HSA-69278
Cell Cycle R-HSA-1640170
Cellular responses to stress R-HSA-2262752
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Cyclin E associated events during G1/S transition R-HSA-69202
Cyclin D associated events in G1 R-HSA-69231
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Chromatin organization R-HSA-4839726
PTK6 Regulates Cell Cycle R-HSA-8849470
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
Diseases of cellular response to stress R-HSA-9675132
Developmental Biology R-HSA-1266738
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Cellular Senescence R-HSA-2559583
Meiotic recombination R-HSA-912446
Cellular responses to stimuli R-HSA-8953897
Chromatin modifying enzymes R-HSA-3247509
Transcriptional regulation of granulopoiesis R-HSA-9616222
Meiosis R-HSA-1500620
Diseases of mitotic cell cycle R-HSA-9675126
Diseases of Cellular Senescence R-HSA-9630747
Generic Transcription Pathway R-HSA-212436
RNA Polymerase II Transcription R-HSA-73857
Disease R-HSA-1643685
S Phase R-HSA-69242
Signaling by PTK6 R-HSA-8848021
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
G1 Phase R-HSA-69236
Oxidative Stress Induced Senescence R-HSA-2559580
Oxidative Stress Induced Senescence R-HSA-2559580
Diseases of cellular response to stress R-HSA-9675132
Cell Cycle, Mitotic R-HSA-69278
Meiosis R-HSA-1500620
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Diseases of Cellular Senescence R-HSA-9630747
S Phase R-HSA-69242
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Signaling by PTK6 R-HSA-8848021
G1/S Transition R-HSA-69206
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Cellular Senescence R-HSA-2559583
Signal Transduction R-HSA-162582
Gene expression (Transcription) R-HSA-74160
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Mitotic G1 phase and G1/S transition R-HSA-453279
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Cell Cycle R-HSA-1640170
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Disease R-HSA-1643685
Cellular responses to stress R-HSA-2262752
Oncogene Induced Senescence R-HSA-2559585
Transcriptional regulation of granulopoiesis R-HSA-9616222
Chromatin organization R-HSA-4839726
Cyclin E associated events during G1/S transition R-HSA-69202
G1 Phase R-HSA-69236
Reproduction R-HSA-1474165
PTK6 Regulates Cell Cycle R-HSA-8849470
Chromatin modifying enzymes R-HSA-3247509
Meiotic recombination R-HSA-912446
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
Cyclin D associated events in G1 R-HSA-69231
Developmental Biology R-HSA-1266738
RMTs methylate histone arginines R-HSA-3214858
RNA Polymerase II Transcription R-HSA-73857
Transcriptional regulation by RUNX2 R-HSA-8878166
Generic Transcription Pathway R-HSA-212436
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Cellular responses to stimuli R-HSA-8953897
Diseases of mitotic cell cycle R-HSA-9675126
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Gene expression (Transcription) R-HSA-74160
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Signaling by PTK6 R-HSA-8848021
Developmental Biology R-HSA-1266738
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
PTK6 Regulates Cell Cycle R-HSA-8849470
Cyclin E associated events during G1/S transition R-HSA-69202
Meiotic recombination R-HSA-912446
Mitotic G1 phase and G1/S transition R-HSA-453279
Cell Cycle, Mitotic R-HSA-69278
Oxidative Stress Induced Senescence R-HSA-2559580
Chromatin modifying enzymes R-HSA-3247509
Reproduction R-HSA-1474165
Diseases of Cellular Senescence R-HSA-9630747
S Phase R-HSA-69242
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
G1 Phase R-HSA-69236
Cellular responses to stimuli R-HSA-8953897
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Transcriptional regulation of granulopoiesis R-HSA-9616222
RNA Polymerase II Transcription R-HSA-73857
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Cellular Senescence R-HSA-2559583
Diseases of mitotic cell cycle R-HSA-9675126
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Cell Cycle R-HSA-1640170
Cellular responses to stress R-HSA-2262752
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
Meiosis R-HSA-1500620
RMTs methylate histone arginines R-HSA-3214858
Chromatin organization R-HSA-4839726
Signal Transduction R-HSA-162582
Oncogene Induced Senescence R-HSA-2559585
Diseases of cellular response to stress R-HSA-9675132
Disease R-HSA-1643685
Generic Transcription Pathway R-HSA-212436
G1/S Transition R-HSA-69206
Cyclin D associated events in G1 R-HSA-69231
Transcriptional regulation by RUNX2 R-HSA-8878166
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Cell Cycle R-HSA-1640170
Meiosis R-HSA-1500620
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750
Diseases of Cellular Senescence R-HSA-9630747
Cell Cycle, Mitotic R-HSA-69278
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787
Cyclin D associated events in G1 R-HSA-69231
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069
Oncogene Induced Senescence R-HSA-2559585
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700
RNA Polymerase II Transcription R-HSA-73857
RMTs methylate histone arginines R-HSA-3214858
PTK6 Regulates Cell Cycle R-HSA-8849470
G1 Phase R-HSA-69236
Gene expression (Transcription) R-HSA-74160
Chromatin organization R-HSA-4839726
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119
S Phase R-HSA-69242
Meiotic recombination R-HSA-912446
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656
Transcriptional regulation by RUNX2 R-HSA-8878166
G1/S Transition R-HSA-69206
Transcriptional regulation of white adipocyte differentiation R-HSA-381340
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582
Transcriptional regulation of granulopoiesis R-HSA-9616222
Chromatin modifying enzymes R-HSA-3247509
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693
Reproduction R-HSA-1474165
Developmental Biology R-HSA-1266738
Signaling by PTK6 R-HSA-8848021
Cellular Senescence R-HSA-2559583
Diseases of cellular response to stress R-HSA-9675132
Cellular responses to stress R-HSA-2262752
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697
Signal Transduction R-HSA-162582
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927
Mitotic G1 phase and G1/S transition R-HSA-453279
Oxidative Stress Induced Senescence R-HSA-2559580
Generic Transcription Pathway R-HSA-212436
Cyclin E associated events during G1/S transition R-HSA-69202
Cellular responses to stimuli R-HSA-8953897
Diseases of mitotic cell cycle R-HSA-9675126
Disease R-HSA-1643685

SARS-CoV-2 Infection R-HSA-9694516
Cilium Assembly R-HSA-5617833
Nervous system development R-HSA-9675108
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Autophagy R-HSA-9612973
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Metabolism of vitamins and cofactors R-HSA-196854
Cell Cycle R-HSA-1640170
Cellular responses to stimuli R-HSA-8953897
Signaling by EGFR in Cancer R-HSA-1643713
Regulated Necrosis R-HSA-5218859
Extra-nuclear estrogen signaling R-HSA-9009391
Signaling by EGFRvIII in Cancer R-HSA-5637812
Infectious disease R-HSA-5663205
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Disease R-HSA-1643685
Signaling by ERBB2 R-HSA-1227986
RIPK1-mediated regulated necrosis R-HSA-5213460
Influenza Viral RNA Transcription and Replication R-HSA-168273
HSF1 activation R-HSA-3371511
Vesicle-mediated transport R-HSA-5653656
vRNP Assembly R-HSA-192905
Scavenging by Class F Receptors R-HSA-3000484
M Phase R-HSA-68886
Signaling by Nuclear Receptors R-HSA-9006931
Signaling by ERBB2 in Cancer R-HSA-1227990
Constitutive Signaling by EGFRvIII R-HSA-5637810
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
SARS-CoV-2-host interactions R-HSA-9705683
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
ESR-mediated signaling R-HSA-8939211
Centrosome maturation R-HSA-380287
Regulation of necroptotic cell death R-HSA-5675482
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Loss of Nlp from mitotic centrosomes R-HSA-380259
SARS-CoV Infections R-HSA-9679506
eNOS activation R-HSA-203615
Metabolism of cofactors R-HSA-8978934
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Uptake and actions of bacterial toxins R-HSA-5339562
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Immune System R-HSA-168256
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
RHO GTPase cycle R-HSA-9012999
Metabolism R-HSA-1430728
Cytokine Signaling in Immune system R-HSA-1280215
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Signaling by ERBB2 KD Mutants R-HSA-9664565
Cellular response to heat stress R-HSA-3371556
Signaling by Interleukins R-HSA-449147
Cell Cycle, Mitotic R-HSA-69278
Signaling by Rho GTPases R-HSA-194315
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Uptake and function of diphtheria toxin R-HSA-5336415
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Downregulation of ERBB2 signaling R-HSA-8863795
Chaperone Mediated Autophagy R-HSA-9613829
Potential therapeutics for SARS R-HSA-9679191
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Macroautophagy R-HSA-1632852
Semaphorin interactions R-HSA-373755
Signaling by ERBB2 ECD mutants R-HSA-9665348
Sema3A PAK dependent Axon repulsion R-HSA-399954
Estrogen-dependent gene expression R-HSA-9018519
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Influenza Infection R-HSA-168255
AURKA Activation by TPX2 R-HSA-8854518
SARS-CoV-2 Infection R-HSA-9694516
Signaling by VEGF R-HSA-194138
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Mitotic G2-G2/M phases R-HSA-453274
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
VEGFR2 mediated vascular permeability R-HSA-5218920
Signal Transduction R-HSA-162582
Attenuation phase R-HSA-3371568
Developmental Biology R-HSA-1266738
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Selective autophagy R-HSA-9663891
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Aggrephagy R-HSA-9646399
Organelle biogenesis and maintenance R-HSA-1852241
Gene Silencing by RNA R-HSA-211000
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Cellular responses to stress R-HSA-2262752
Gene expression (Transcription) R-HSA-74160
Programmed Cell Death R-HSA-5357801
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Innate Immune System R-HSA-168249
Axon guidance R-HSA-422475
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
G2/M Transition R-HSA-69275
Mitotic Prometaphase R-HSA-68877
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
HSF1-dependent transactivation R-HSA-3371571
Neutrophil degranulation R-HSA-6798695
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
RHOBTB GTPase Cycle R-HSA-9706574
RHOBTB2 GTPase cycle R-HSA-9013418
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
VEGFA-VEGFR2 Pathway R-HSA-4420097
Sema3A PAK dependent Axon repulsion R-HSA-399954
Cilium Assembly R-HSA-5617833
Cell Cycle R-HSA-1640170
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Mitotic G2-G2/M phases R-HSA-453274
Extra-nuclear estrogen signaling R-HSA-9009391
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
AURKA Activation by TPX2 R-HSA-8854518
Metabolism of vitamins and cofactors R-HSA-196854
Cellular response to heat stress R-HSA-3371556
Developmental Biology R-HSA-1266738
Programmed Cell Death R-HSA-5357801
Selective autophagy R-HSA-9663891
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Influenza Viral RNA Transcription and Replication R-HSA-168273
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Aggrephagy R-HSA-9646399
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
RIPK1-mediated regulated necrosis R-HSA-5213460
Signaling by ERBB2 KD Mutants R-HSA-9664565
Estrogen-dependent gene expression R-HSA-9018519
VEGFA-VEGFR2 Pathway R-HSA-4420097
G2/M Transition R-HSA-69275
Axon guidance R-HSA-422475
Cellular responses to stress R-HSA-2262752
Signaling by ERBB2 R-HSA-1227986
Uptake and function of diphtheria toxin R-HSA-5336415
Influenza Infection R-HSA-168255
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
RHOBTB2 GTPase cycle R-HSA-9013418
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
SARS-CoV-2-host interactions R-HSA-9705683
Signaling by Rho GTPases R-HSA-194315
Vesicle-mediated transport R-HSA-5653656
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Signal Transduction R-HSA-162582
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Semaphorin interactions R-HSA-373755
Metabolism of cofactors R-HSA-8978934
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Gene Silencing by RNA R-HSA-211000
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Signaling by EGFR in Cancer R-HSA-1643713
VEGFR2 mediated vascular permeability R-HSA-5218920
Disease R-HSA-1643685
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Attenuation phase R-HSA-3371568
Regulation of necroptotic cell death R-HSA-5675482
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Regulated Necrosis R-HSA-5218859
Signaling by EGFRvIII in Cancer R-HSA-5637812
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Signaling by Nuclear Receptors R-HSA-9006931
Autophagy R-HSA-9612973
Scavenging by Class F Receptors R-HSA-3000484
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by ERBB2 ECD mutants R-HSA-9665348
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Nervous system development R-HSA-9675108
HSF1-dependent transactivation R-HSA-3371571
RHO GTPase cycle R-HSA-9012999
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Mitotic Prometaphase R-HSA-68877
SARS-CoV-2 Infection R-HSA-9694516
Macroautophagy R-HSA-1632852
Downregulation of ERBB2 signaling R-HSA-8863795
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Signaling by Interleukins R-HSA-449147
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Signaling by ERBB2 in Cancer R-HSA-1227990
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
SARS-CoV Infections R-HSA-9679506
Signaling by VEGF R-HSA-194138
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
RHOBTB GTPase Cycle R-HSA-9706574
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Gene expression (Transcription) R-HSA-74160
Neutrophil degranulation R-HSA-6798695
ESR-mediated signaling R-HSA-8939211
Cell Cycle, Mitotic R-HSA-69278
Innate Immune System R-HSA-168249
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Organelle biogenesis and maintenance R-HSA-1852241
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
M Phase R-HSA-68886
eNOS activation R-HSA-203615
Cellular responses to stimuli R-HSA-8953897
Chaperone Mediated Autophagy R-HSA-9613829
Metabolism R-HSA-1430728
Constitutive Signaling by EGFRvIII R-HSA-5637810
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Centrosome maturation R-HSA-380287
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Uptake and actions of bacterial toxins R-HSA-5339562
HSF1 activation R-HSA-3371511
Infectious disease R-HSA-5663205
vRNP Assembly R-HSA-192905
Loss of Nlp from mitotic centrosomes R-HSA-380259
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Potential therapeutics for SARS R-HSA-9679191
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Sema3A PAK dependent Axon repulsion R-HSA-399954
Cellular response to heat stress R-HSA-3371556
Signaling by VEGF R-HSA-194138
Regulation of necroptotic cell death R-HSA-5675482
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Attenuation phase R-HSA-3371568
SARS-CoV Infections R-HSA-9679506
Cytokine Signaling in Immune system R-HSA-1280215
Metabolism R-HSA-1430728
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Innate Immune System R-HSA-168249
RIPK1-mediated regulated necrosis R-HSA-5213460
RHOBTB GTPase Cycle R-HSA-9706574
Macroautophagy R-HSA-1632852
Autophagy R-HSA-9612973
vRNP Assembly R-HSA-192905
Gene Silencing by RNA R-HSA-211000
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Immune System R-HSA-168256
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Mitotic G2-G2/M phases R-HSA-453274
Cellular responses to stress R-HSA-2262752
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
VEGFR2 mediated vascular permeability R-HSA-5218920
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Chaperone Mediated Autophagy R-HSA-9613829
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Constitutive Signaling by EGFRvIII R-HSA-5637810
Cell Cycle R-HSA-1640170
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Mitotic Prometaphase R-HSA-68877
Downregulation of ERBB2 signaling R-HSA-8863795
Aggrephagy R-HSA-9646399
Potential therapeutics for SARS R-HSA-9679191
G2/M Transition R-HSA-69275
AURKA Activation by TPX2 R-HSA-8854518
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Nervous system development R-HSA-9675108
Regulated Necrosis R-HSA-5218859
Signaling by ERBB2 KD Mutants R-HSA-9664565
Loss of Nlp from mitotic centrosomes R-HSA-380259
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Signaling by ERBB2 ECD mutants R-HSA-9665348
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Gene expression (Transcription) R-HSA-74160
RHOBTB2 GTPase cycle R-HSA-9013418
Signaling by Interleukins R-HSA-449147
VEGFA-VEGFR2 Pathway R-HSA-4420097
Metabolism of cofactors R-HSA-8978934
SARS-CoV-2-host interactions R-HSA-9705683
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
RHO GTPase cycle R-HSA-9012999
HSF1-dependent transactivation R-HSA-3371571
Signaling by ERBB2 in Cancer R-HSA-1227990
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
HSF1 activation R-HSA-3371511
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Metabolism of vitamins and cofactors R-HSA-196854
eNOS activation R-HSA-203615
Organelle biogenesis and maintenance R-HSA-1852241
Centrosome maturation R-HSA-380287
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Selective autophagy R-HSA-9663891
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Signaling by EGFR in Cancer R-HSA-1643713
Extra-nuclear estrogen signaling R-HSA-9009391
Signal Transduction R-HSA-162582
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Cilium Assembly R-HSA-5617833
Signaling by Nuclear Receptors R-HSA-9006931
Semaphorin interactions R-HSA-373755
Uptake and function of diphtheria toxin R-HSA-5336415
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Uptake and actions of bacterial toxins R-HSA-5339562
Signaling by ERBB2 R-HSA-1227986
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
ESR-mediated signaling R-HSA-8939211
Signaling by EGFRvIII in Cancer R-HSA-5637812
Influenza Infection R-HSA-168255
Programmed Cell Death R-HSA-5357801
Vesicle-mediated transport R-HSA-5653656
Cellular responses to stimuli R-HSA-8953897
Cell Cycle, Mitotic R-HSA-69278
Scavenging by Class F Receptors R-HSA-3000484
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Estrogen-dependent gene expression R-HSA-9018519
M Phase R-HSA-68886
Infectious disease R-HSA-5663205
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Disease R-HSA-1643685
Axon guidance R-HSA-422475
Developmental Biology R-HSA-1266738
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Influenza Viral RNA Transcription and Replication R-HSA-168273
Signaling by Rho GTPases R-HSA-194315
Neutrophil degranulation R-HSA-6798695
Anchoring of the basal body to the plasma membrane R-HSA-5620912
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
RHOBTB GTPase Cycle R-HSA-9706574
Signaling by ERBB2 KD Mutants R-HSA-9664565
Signaling by VEGF R-HSA-194138
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
RHO GTPase cycle R-HSA-9012999
Extra-nuclear estrogen signaling R-HSA-9009391
Metabolism of cofactors R-HSA-8978934
Signaling by Rho GTPases R-HSA-194315
Scavenging by Class F Receptors R-HSA-3000484
AURKA Activation by TPX2 R-HSA-8854518
Regulation of necroptotic cell death R-HSA-5675482
SARS-CoV-2 Infection R-HSA-9694516
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
M Phase R-HSA-68886
Constitutive Signaling by EGFRvIII R-HSA-5637810
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Signaling by Interleukins R-HSA-449147
Semaphorin interactions R-HSA-373755
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Disease R-HSA-1643685
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
vRNP Assembly R-HSA-192905
SARS-CoV-2-host interactions R-HSA-9705683
Chaperone Mediated Autophagy R-HSA-9613829
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Mitotic G2-G2/M phases R-HSA-453274
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Influenza Infection R-HSA-168255
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
eNOS activation R-HSA-203615
Metabolism of vitamins and cofactors R-HSA-196854
Cilium Assembly R-HSA-5617833
Cell Cycle, Mitotic R-HSA-69278
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Selective autophagy R-HSA-9663891
Immune System R-HSA-168256
Autophagy R-HSA-9612973
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
RIPK1-mediated regulated necrosis R-HSA-5213460
Developmental Biology R-HSA-1266738
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Loss of Nlp from mitotic centrosomes R-HSA-380259
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Aggrephagy R-HSA-9646399
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Innate Immune System R-HSA-168249
VEGFR2 mediated vascular permeability R-HSA-5218920
HSF1 activation R-HSA-3371511
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Mitotic Prometaphase R-HSA-68877
Centrosome maturation R-HSA-380287
RHOBTB2 GTPase cycle R-HSA-9013418
Attenuation phase R-HSA-3371568
VEGFA-VEGFR2 Pathway R-HSA-4420097
Sema3A PAK dependent Axon repulsion R-HSA-399954
Estrogen-dependent gene expression R-HSA-9018519
Potential therapeutics for SARS R-HSA-9679191
Organelle biogenesis and maintenance R-HSA-1852241
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
HSF1-dependent transactivation R-HSA-3371571
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Uptake and function of diphtheria toxin R-HSA-5336415
Axon guidance R-HSA-422475
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Downregulation of ERBB2 signaling R-HSA-8863795
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Regulated Necrosis R-HSA-5218859
Cellular responses to stimuli R-HSA-8953897
Cellular response to heat stress R-HSA-3371556
Signaling by Nuclear Receptors R-HSA-9006931
Signaling by ERBB2 R-HSA-1227986
Signaling by ERBB2 in Cancer R-HSA-1227990
Nervous system development R-HSA-9675108
Signal Transduction R-HSA-162582
Metabolism R-HSA-1430728
Vesicle-mediated transport R-HSA-5653656
Gene Silencing by RNA R-HSA-211000
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Influenza Viral RNA Transcription and Replication R-HSA-168273
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Programmed Cell Death R-HSA-5357801
ESR-mediated signaling R-HSA-8939211
Signaling by ERBB2 ECD mutants R-HSA-9665348
Uptake and actions of bacterial toxins R-HSA-5339562
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
SARS-CoV Infections R-HSA-9679506
Signaling by EGFR in Cancer R-HSA-1643713
Signaling by EGFRvIII in Cancer R-HSA-5637812
Macroautophagy R-HSA-1632852
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Gene expression (Transcription) R-HSA-74160
Cellular responses to stress R-HSA-2262752
Neutrophil degranulation R-HSA-6798695
Cell Cycle R-HSA-1640170
Cytokine Signaling in Immune system R-HSA-1280215
Infectious disease R-HSA-5663205
G2/M Transition R-HSA-69275
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
VEGFR2 mediated vascular permeability R-HSA-5218920
Programmed Cell Death R-HSA-5357801
Cell Cycle R-HSA-1640170
Uptake and function of diphtheria toxin R-HSA-5336415
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
SARS-CoV Infections R-HSA-9679506
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Cytokine Signaling in Immune system R-HSA-1280215
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Neutrophil degranulation R-HSA-6798695
Developmental Biology R-HSA-1266738
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Extra-nuclear estrogen signaling R-HSA-9009391
Signaling by Nuclear Receptors R-HSA-9006931
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Loss of Nlp from mitotic centrosomes R-HSA-380259
Estrogen-dependent gene expression R-HSA-9018519
Metabolism of cofactors R-HSA-8978934
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Gene expression (Transcription) R-HSA-74160
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Cellular responses to stimuli R-HSA-8953897
Signaling by EGFRvIII in Cancer R-HSA-5637812
HSF1 activation R-HSA-3371511
Constitutive Signaling by EGFRvIII R-HSA-5637810
Signaling by ERBB2 in Cancer R-HSA-1227990
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
M Phase R-HSA-68886
Signaling by ERBB2 R-HSA-1227986
Innate Immune System R-HSA-168249
SARS-CoV-2-host interactions R-HSA-9705683
Infectious disease R-HSA-5663205
Sema3A PAK dependent Axon repulsion R-HSA-399954
Cellular responses to stress R-HSA-2262752
Drug resistance in ERBB2 KD mutants R-HSA-9665230
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Autophagy R-HSA-9612973
Cilium Assembly R-HSA-5617833
Aggrephagy R-HSA-9646399
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Chaperone Mediated Autophagy R-HSA-9613829
Signaling by Interleukins R-HSA-449147
vRNP Assembly R-HSA-192905
Vesicle-mediated transport R-HSA-5653656
Disease R-HSA-1643685
Metabolism R-HSA-1430728
Attenuation phase R-HSA-3371568
Mitotic G2-G2/M phases R-HSA-453274
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Macroautophagy R-HSA-1632852
Immune System R-HSA-168256
Mitotic Prometaphase R-HSA-68877
Cell Cycle, Mitotic R-HSA-69278
ESR-mediated signaling R-HSA-8939211
RHOBTB GTPase Cycle R-HSA-9706574
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Regulated Necrosis R-HSA-5218859
Signaling by VEGF R-HSA-194138
RHO GTPase cycle R-HSA-9012999
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Influenza Infection R-HSA-168255
Axon guidance R-HSA-422475
Signaling by Rho GTPases R-HSA-194315
Signaling by ERBB2 ECD mutants R-HSA-9665348
G2/M Transition R-HSA-69275
Signaling by EGFR in Cancer R-HSA-1643713
AURKA Activation by TPX2 R-HSA-8854518
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Scavenging by Class F Receptors R-HSA-3000484
Downregulation of ERBB2 signaling R-HSA-8863795
VEGFA-VEGFR2 Pathway R-HSA-4420097
SARS-CoV-2 Infection R-HSA-9694516
Selective autophagy R-HSA-9663891
RHOBTB2 GTPase cycle R-HSA-9013418
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Influenza Viral RNA Transcription and Replication R-HSA-168273
Cellular response to heat stress R-HSA-3371556
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Metabolism of vitamins and cofactors R-HSA-196854
Semaphorin interactions R-HSA-373755
Organelle biogenesis and maintenance R-HSA-1852241
Nervous system development R-HSA-9675108
Regulation of necroptotic cell death R-HSA-5675482
RIPK1-mediated regulated necrosis R-HSA-5213460
HSF1-dependent transactivation R-HSA-3371571
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Signaling by ERBB2 KD Mutants R-HSA-9664565
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
eNOS activation R-HSA-203615
Uptake and actions of bacterial toxins R-HSA-5339562
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Centrosome maturation R-HSA-380287
Signal Transduction R-HSA-162582
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Gene Silencing by RNA R-HSA-211000
Potential therapeutics for SARS R-HSA-9679191
G2/M Transition R-HSA-69275
Influenza Viral RNA Transcription and Replication R-HSA-168273
HSF1-dependent transactivation R-HSA-3371571
Uptake and actions of bacterial toxins R-HSA-5339562
Centrosome maturation R-HSA-380287
Mitotic G2-G2/M phases R-HSA-453274
Signaling by EGFR in Cancer R-HSA-1643713
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Regulation of necroptotic cell death R-HSA-5675482
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Chaperone Mediated Autophagy R-HSA-9613829
Cellular responses to stimuli R-HSA-8953897
SARS-CoV-2 Infection R-HSA-9694516
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Vesicle-mediated transport R-HSA-5653656
AURKA Activation by TPX2 R-HSA-8854518
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Infectious disease R-HSA-5663205
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Signaling by EGFRvIII in Cancer R-HSA-5637812
Gene expression (Transcription) R-HSA-74160
SARS-CoV-2-host interactions R-HSA-9705683
Immune System R-HSA-168256
Metabolism of vitamins and cofactors R-HSA-196854
Signaling by Interleukins R-HSA-449147
Signaling by ERBB2 KD Mutants R-HSA-9664565
Aggrephagy R-HSA-9646399
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Signaling by Rho GTPases R-HSA-194315
Scavenging by Class F Receptors R-HSA-3000484
Nervous system development R-HSA-9675108
Programmed Cell Death R-HSA-5357801
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Influenza Infection R-HSA-168255
Estrogen-dependent gene expression R-HSA-9018519
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Loss of Nlp from mitotic centrosomes R-HSA-380259
Semaphorin interactions R-HSA-373755
ESR-mediated signaling R-HSA-8939211
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Constitutive Signaling by EGFRvIII R-HSA-5637810
Organelle biogenesis and maintenance R-HSA-1852241
RHOBTB GTPase Cycle R-HSA-9706574
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Sema3A PAK dependent Axon repulsion R-HSA-399954
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Disease R-HSA-1643685
Extra-nuclear estrogen signaling R-HSA-9009391
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Potential therapeutics for SARS R-HSA-9679191
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Axon guidance R-HSA-422475
Regulated Necrosis R-HSA-5218859
Cell Cycle R-HSA-1640170
RHO GTPase cycle R-HSA-9012999
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Signaling by ERBB2 ECD mutants R-HSA-9665348
Cellular response to heat stress R-HSA-3371556
Neutrophil degranulation R-HSA-6798695
Signaling by VEGF R-HSA-194138
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Macroautophagy R-HSA-1632852
Attenuation phase R-HSA-3371568
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Selective autophagy R-HSA-9663891
VEGFR2 mediated vascular permeability R-HSA-5218920
eNOS activation R-HSA-203615
Signaling by ERBB2 in Cancer R-HSA-1227990
RHOBTB2 GTPase cycle R-HSA-9013418
Autophagy R-HSA-9612973
Signaling by ERBB2 R-HSA-1227986
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Uptake and function of diphtheria toxin R-HSA-5336415
Cilium Assembly R-HSA-5617833
vRNP Assembly R-HSA-192905
Downregulation of ERBB2 signaling R-HSA-8863795
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Innate Immune System R-HSA-168249
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Metabolism R-HSA-1430728
Cell Cycle, Mitotic R-HSA-69278
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Mitotic Prometaphase R-HSA-68877
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Cellular responses to stress R-HSA-2262752
Signaling by Nuclear Receptors R-HSA-9006931
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
RIPK1-mediated regulated necrosis R-HSA-5213460
Metabolism of cofactors R-HSA-8978934
Developmental Biology R-HSA-1266738
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
VEGFA-VEGFR2 Pathway R-HSA-4420097
HSF1 activation R-HSA-3371511
Gene Silencing by RNA R-HSA-211000
Cytokine Signaling in Immune system R-HSA-1280215
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Signal Transduction R-HSA-162582
M Phase R-HSA-68886
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
SARS-CoV Infections R-HSA-9679506
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Developmental Biology R-HSA-1266738
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
RHOBTB GTPase Cycle R-HSA-9706574
VEGFR2 mediated vascular permeability R-HSA-5218920
Semaphorin interactions R-HSA-373755
Downregulation of ERBB2 signaling R-HSA-8863795
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Selective autophagy R-HSA-9663891
Uptake and actions of bacterial toxins R-HSA-5339562
Vesicle-mediated transport R-HSA-5653656
Influenza Infection R-HSA-168255
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Aggrephagy R-HSA-9646399
Cellular responses to stimuli R-HSA-8953897
vRNP Assembly R-HSA-192905
Cytokine Signaling in Immune system R-HSA-1280215
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Signaling by Interleukins R-HSA-449147
Cilium Assembly R-HSA-5617833
Autophagy R-HSA-9612973
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Signaling by ERBB2 in Cancer R-HSA-1227990
HSF1 activation R-HSA-3371511
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Uptake and function of diphtheria toxin R-HSA-5336415
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by Nuclear Receptors R-HSA-9006931
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Loss of Nlp from mitotic centrosomes R-HSA-380259
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Estrogen-dependent gene expression R-HSA-9018519
RIPK1-mediated regulated necrosis R-HSA-5213460
Macroautophagy R-HSA-1632852
Signaling by EGFRvIII in Cancer R-HSA-5637812
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
HSF1-dependent transactivation R-HSA-3371571
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
SARS-CoV-2 Infection R-HSA-9694516
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Programmed Cell Death R-HSA-5357801
Influenza Viral RNA Transcription and Replication R-HSA-168273
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
AURKA Activation by TPX2 R-HSA-8854518
Cell Cycle, Mitotic R-HSA-69278
Extra-nuclear estrogen signaling R-HSA-9009391
Innate Immune System R-HSA-168249
Metabolism of vitamins and cofactors R-HSA-196854
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Nervous system development R-HSA-9675108
Signaling by ERBB2 KD Mutants R-HSA-9664565
RHOBTB2 GTPase cycle R-HSA-9013418
Organelle biogenesis and maintenance R-HSA-1852241
Regulated Necrosis R-HSA-5218859
Metabolism of cofactors R-HSA-8978934
Mitotic Prometaphase R-HSA-68877
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Scavenging by Class F Receptors R-HSA-3000484
Centrosome maturation R-HSA-380287
RHO GTPase cycle R-HSA-9012999
Signaling by ERBB2 R-HSA-1227986
Chaperone Mediated Autophagy R-HSA-9613829
Axon guidance R-HSA-422475
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
M Phase R-HSA-68886
Gene expression (Transcription) R-HSA-74160
Sema3A PAK dependent Axon repulsion R-HSA-399954
Attenuation phase R-HSA-3371568
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Potential therapeutics for SARS R-HSA-9679191
Signal Transduction R-HSA-162582
Cell Cycle R-HSA-1640170
Cellular responses to stress R-HSA-2262752
Constitutive Signaling by EGFRvIII R-HSA-5637810
Signaling by EGFR in Cancer R-HSA-1643713
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Regulation of necroptotic cell death R-HSA-5675482
Metabolism R-HSA-1430728
Signaling by ERBB2 ECD mutants R-HSA-9665348
Disease R-HSA-1643685
Neutrophil degranulation R-HSA-6798695
Mitotic G2-G2/M phases R-HSA-453274
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Signaling by VEGF R-HSA-194138
SARS-CoV-2-host interactions R-HSA-9705683
ESR-mediated signaling R-HSA-8939211
VEGFA-VEGFR2 Pathway R-HSA-4420097
SARS-CoV Infections R-HSA-9679506
Infectious disease R-HSA-5663205
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
G2/M Transition R-HSA-69275
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Cellular response to heat stress R-HSA-3371556
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Gene Silencing by RNA R-HSA-211000
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Signaling by Rho GTPases R-HSA-194315
eNOS activation R-HSA-203615
RHOBTB GTPase Cycle R-HSA-9706574
Metabolism R-HSA-1430728
eNOS activation R-HSA-203615
Innate Immune System R-HSA-168249
Potential therapeutics for SARS R-HSA-9679191
vRNP Assembly R-HSA-192905
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Attenuation phase R-HSA-3371568
Chaperone Mediated Autophagy R-HSA-9613829
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Signaling by EGFRvIII in Cancer R-HSA-5637812
Cellular responses to stress R-HSA-2262752
SARS-CoV-2-host interactions R-HSA-9705683
Signaling by Nuclear Receptors R-HSA-9006931
Gene Silencing by RNA R-HSA-211000
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Axon guidance R-HSA-422475
Uptake and function of diphtheria toxin R-HSA-5336415
RHOBTB2 GTPase cycle R-HSA-9013418
Nervous system development R-HSA-9675108
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Drug resistance in ERBB2 KD mutants R-HSA-9665230
M Phase R-HSA-68886
AURKA Activation by TPX2 R-HSA-8854518
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Selective autophagy R-HSA-9663891
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Signaling by VEGF R-HSA-194138
Vesicle-mediated transport R-HSA-5653656
Signaling by ERBB2 R-HSA-1227986
Cellular responses to stimuli R-HSA-8953897
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Developmental Biology R-HSA-1266738
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Neutrophil degranulation R-HSA-6798695
Sema3A PAK dependent Axon repulsion R-HSA-399954
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Scavenging by Class F Receptors R-HSA-3000484
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
RIPK1-mediated regulated necrosis R-HSA-5213460
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Disease R-HSA-1643685
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Cell Cycle R-HSA-1640170
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Regulation of necroptotic cell death R-HSA-5675482
Signaling by ERBB2 ECD mutants R-HSA-9665348
Signaling by Interleukins R-HSA-449147
Metabolism of vitamins and cofactors R-HSA-196854
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Aggrephagy R-HSA-9646399
Semaphorin interactions R-HSA-373755
Signaling by ERBB2 KD Mutants R-HSA-9664565
SARS-CoV Infections R-HSA-9679506
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
ESR-mediated signaling R-HSA-8939211
Signal Transduction R-HSA-162582
SARS-CoV-2 Infection R-HSA-9694516
Mitotic Prometaphase R-HSA-68877
Gene expression (Transcription) R-HSA-74160
Constitutive Signaling by EGFRvIII R-HSA-5637810
HSF1-dependent transactivation R-HSA-3371571
Uptake and actions of bacterial toxins R-HSA-5339562
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Signaling by ERBB2 in Cancer R-HSA-1227990
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Downregulation of ERBB2 signaling R-HSA-8863795
Cellular response to heat stress R-HSA-3371556
Signaling by EGFR in Cancer R-HSA-1643713
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
Signaling by Rho GTPases R-HSA-194315
Estrogen-dependent gene expression R-HSA-9018519
Immune System R-HSA-168256
Cilium Assembly R-HSA-5617833
Programmed Cell Death R-HSA-5357801
Regulated Necrosis R-HSA-5218859
VEGFR2 mediated vascular permeability R-HSA-5218920
Influenza Viral RNA Transcription and Replication R-HSA-168273
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
VEGFA-VEGFR2 Pathway R-HSA-4420097
Influenza Infection R-HSA-168255
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
G2/M Transition R-HSA-69275
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Cell Cycle, Mitotic R-HSA-69278
Metabolism of cofactors R-HSA-8978934
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Infectious disease R-HSA-5663205
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
RHO GTPase cycle R-HSA-9012999
Cytokine Signaling in Immune system R-HSA-1280215
Autophagy R-HSA-9612973
Mitotic G2-G2/M phases R-HSA-453274
Organelle biogenesis and maintenance R-HSA-1852241
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Loss of Nlp from mitotic centrosomes R-HSA-380259
Macroautophagy R-HSA-1632852
Extra-nuclear estrogen signaling R-HSA-9009391
HSF1 activation R-HSA-3371511
Centrosome maturation R-HSA-380287
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Organelle biogenesis and maintenance R-HSA-1852241
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
HSF1-dependent transactivation R-HSA-3371571
Signaling by Interleukins R-HSA-449147
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Influenza Infection R-HSA-168255
Signal Transduction R-HSA-162582
Semaphorin interactions R-HSA-373755
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
eNOS activation R-HSA-203615
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Mitotic Prometaphase R-HSA-68877
Attenuation phase R-HSA-3371568
SARS-CoV Infections R-HSA-9679506
ESR-mediated signaling R-HSA-8939211
Uptake and actions of bacterial toxins R-HSA-5339562
G2/M Transition R-HSA-69275
Disease R-HSA-1643685
Programmed Cell Death R-HSA-5357801
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Constitutive Signaling by EGFRvIII R-HSA-5637810
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Centrosome maturation R-HSA-380287
Signaling by ERBB2 KD Mutants R-HSA-9664565
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Metabolism R-HSA-1430728
Autophagy R-HSA-9612973
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Selective autophagy R-HSA-9663891
Cellular responses to stimuli R-HSA-8953897
RHO GTPase cycle R-HSA-9012999
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Regulated Necrosis R-HSA-5218859
Neutrophil degranulation R-HSA-6798695
Signaling by Nuclear Receptors R-HSA-9006931
Regulation of necroptotic cell death R-HSA-5675482
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Sema3A PAK dependent Axon repulsion R-HSA-399954
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Cellular responses to stress R-HSA-2262752
HSF1 activation R-HSA-3371511
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Nervous system development R-HSA-9675108
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Gene Silencing by RNA R-HSA-211000
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Potential therapeutics for SARS R-HSA-9679191
Signaling by ERBB2 in Cancer R-HSA-1227990
SARS-CoV-2-host interactions R-HSA-9705683
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Innate Immune System R-HSA-168249
Developmental Biology R-HSA-1266738
Estrogen-dependent gene expression R-HSA-9018519
Aggrephagy R-HSA-9646399
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
VEGFA-VEGFR2 Pathway R-HSA-4420097
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Uptake and function of diphtheria toxin R-HSA-5336415
Signaling by EGFR in Cancer R-HSA-1643713
Downregulation of ERBB2 signaling R-HSA-8863795
RIPK1-mediated regulated necrosis R-HSA-5213460
Vesicle-mediated transport R-HSA-5653656
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
RHOBTB2 GTPase cycle R-HSA-9013418
M Phase R-HSA-68886
Loss of Nlp from mitotic centrosomes R-HSA-380259
Signaling by ERBB2 ECD mutants R-HSA-9665348
Cilium Assembly R-HSA-5617833
Scavenging by Class F Receptors R-HSA-3000484
Gene expression (Transcription) R-HSA-74160
Cell Cycle R-HSA-1640170
Chaperone Mediated Autophagy R-HSA-9613829
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Signaling by VEGF R-HSA-194138
SARS-CoV-2 Infection R-HSA-9694516
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Cytokine Signaling in Immune system R-HSA-1280215
Infectious disease R-HSA-5663205
AURKA Activation by TPX2 R-HSA-8854518
VEGFR2 mediated vascular permeability R-HSA-5218920
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Cell Cycle, Mitotic R-HSA-69278
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
vRNP Assembly R-HSA-192905
Signaling by EGFRvIII in Cancer R-HSA-5637812
Influenza Viral RNA Transcription and Replication R-HSA-168273
Cellular response to heat stress R-HSA-3371556
Signaling by Rho GTPases R-HSA-194315
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Signaling by ERBB2 R-HSA-1227986
Extra-nuclear estrogen signaling R-HSA-9009391
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Metabolism of cofactors R-HSA-8978934
Anchoring of the basal body to the plasma membrane R-HSA-5620912
RHOBTB GTPase Cycle R-HSA-9706574
Macroautophagy R-HSA-1632852
Axon guidance R-HSA-422475
Immune System R-HSA-168256
Mitotic G2-G2/M phases R-HSA-453274
Metabolism of vitamins and cofactors R-HSA-196854
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Cellular responses to stimuli R-HSA-8953897
HSF1-dependent transactivation R-HSA-3371571
Cellular responses to stress R-HSA-2262752
Gene Silencing by RNA R-HSA-211000
Uptake and actions of bacterial toxins R-HSA-5339562
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
G2/M Transition R-HSA-69275
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Autophagy R-HSA-9612973
Regulated Necrosis R-HSA-5218859
VEGFR2 mediated vascular permeability R-HSA-5218920
M Phase R-HSA-68886
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
Loss of Nlp from mitotic centrosomes R-HSA-380259
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Nervous system development R-HSA-9675108
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Cilium Assembly R-HSA-5617833
Signaling by Interleukins R-HSA-449147
Semaphorin interactions R-HSA-373755
Signaling by Rho GTPases R-HSA-194315
Metabolism R-HSA-1430728
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Innate Immune System R-HSA-168249
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Influenza Infection R-HSA-168255
Signaling by EGFRvIII in Cancer R-HSA-5637812
Macroautophagy R-HSA-1632852
vRNP Assembly R-HSA-192905
Cell Cycle, Mitotic R-HSA-69278
Programmed Cell Death R-HSA-5357801
Scavenging by Class F Receptors R-HSA-3000484
Axon guidance R-HSA-422475
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Selective autophagy R-HSA-9663891
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Immune System R-HSA-168256
Aggrephagy R-HSA-9646399
SARS-CoV-2 Infection R-HSA-9694516
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Signal Transduction R-HSA-162582
Cell Cycle R-HSA-1640170
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Influenza Viral RNA Transcription and Replication R-HSA-168273
Neutrophil degranulation R-HSA-6798695
Cellular response to heat stress R-HSA-3371556
Developmental Biology R-HSA-1266738
RIPK1-mediated regulated necrosis R-HSA-5213460
Organelle biogenesis and maintenance R-HSA-1852241
Signaling by Nuclear Receptors R-HSA-9006931
Infectious disease R-HSA-5663205
Metabolism of cofactors R-HSA-8978934
eNOS activation R-HSA-203615
Sema3A PAK dependent Axon repulsion R-HSA-399954
Uptake and function of diphtheria toxin R-HSA-5336415
Signaling by EGFR in Cancer R-HSA-1643713
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Metabolism of vitamins and cofactors R-HSA-196854
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
RHO GTPase cycle R-HSA-9012999
Extra-nuclear estrogen signaling R-HSA-9009391
Mitotic G2-G2/M phases R-HSA-453274
RHOBTB GTPase Cycle R-HSA-9706574
Signaling by ERBB2 R-HSA-1227986
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Signaling by ERBB2 KD Mutants R-HSA-9664565
Potential therapeutics for SARS R-HSA-9679191
Attenuation phase R-HSA-3371568
Disease R-HSA-1643685
Signaling by ERBB2 ECD mutants R-HSA-9665348
Gene expression (Transcription) R-HSA-74160
Downregulation of ERBB2 signaling R-HSA-8863795
Constitutive Signaling by EGFRvIII R-HSA-5637810
Cytokine Signaling in Immune system R-HSA-1280215
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
AURKA Activation by TPX2 R-HSA-8854518
Centrosome maturation R-HSA-380287
RHOBTB2 GTPase cycle R-HSA-9013418
SARS-CoV-2-host interactions R-HSA-9705683
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
Estrogen-dependent gene expression R-HSA-9018519
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
VEGFA-VEGFR2 Pathway R-HSA-4420097
Vesicle-mediated transport R-HSA-5653656
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Chaperone Mediated Autophagy R-HSA-9613829
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
ESR-mediated signaling R-HSA-8939211
HSF1 activation R-HSA-3371511
Regulation of necroptotic cell death R-HSA-5675482
Signaling by ERBB2 in Cancer R-HSA-1227990
Signaling by VEGF R-HSA-194138
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
SARS-CoV Infections R-HSA-9679506
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Mitotic Prometaphase R-HSA-68877
Cilium Assembly R-HSA-5617833
Programmed Cell Death R-HSA-5357801
Attenuation phase R-HSA-3371568
Signaling by EGFR in Cancer R-HSA-1643713
Potential therapeutics for SARS R-HSA-9679191
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251
Centrosome maturation R-HSA-380287
Regulated Necrosis R-HSA-5218859
RHO GTPase cycle R-HSA-9012999
ESR-mediated signaling R-HSA-8939211
Scavenging by Class F Receptors R-HSA-3000484
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233
Mitotic G2-G2/M phases R-HSA-453274
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151
Cell Cycle R-HSA-1640170
vRNP Assembly R-HSA-192905
RIPK1-mediated regulated necrosis R-HSA-5213460
Anchoring of the basal body to the plasma membrane R-HSA-5620912
Signaling by ERBB2 KD Mutants R-HSA-9664565
Estrogen-dependent gene expression R-HSA-9018519
Gene expression (Transcription) R-HSA-74160
RHOBTB GTPase Cycle R-HSA-9706574
SARS-CoV-2-host interactions R-HSA-9705683
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942
Signaling by VEGF R-HSA-194138
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247
Aggrephagy R-HSA-9646399
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244
Extra-nuclear estrogen signaling R-HSA-9009391
Recruitment of NuMA to mitotic centrosomes R-HSA-380320
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Mitotic Prometaphase R-HSA-68877
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928
Regulation of necroptotic cell death R-HSA-5675482
AURKA Activation by TPX2 R-HSA-8854518
Uptake and function of diphtheria toxin R-HSA-5336415
Signaling by Nuclear Receptors R-HSA-9006931
Axon guidance R-HSA-422475
Immune System R-HSA-168256
Nervous system development R-HSA-9675108
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782
Influenza Infection R-HSA-168255
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282
SARS-CoV Infections R-HSA-9679506
Signal Transduction R-HSA-162582
Downregulation of ERBB2 signaling R-HSA-8863795
Cellular responses to stress R-HSA-2262752
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807
M Phase R-HSA-68886
VEGFA-VEGFR2 Pathway R-HSA-4420097
RHOBTB2 GTPase cycle R-HSA-9013418
Metabolism R-HSA-1430728
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
HSF1-dependent transactivation R-HSA-3371571
Signaling by Interleukins R-HSA-449147
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686
Neutrophil degranulation R-HSA-6798695
Metabolism of cofactors R-HSA-8978934
Sema3A PAK dependent Axon repulsion R-HSA-399954
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276
SARS-CoV-2 Infection R-HSA-9694516
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884
Signaling by ERBB2 in Cancer R-HSA-1227990
Signaling by EGFRvIII in Cancer R-HSA-5637812
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497
Constitutive Signaling by EGFRvIII R-HSA-5637810
Uptake and actions of bacterial toxins R-HSA-5339562
Drug resistance in ERBB2 KD mutants R-HSA-9665230
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815
Innate Immune System R-HSA-168249
Vesicle-mediated transport R-HSA-5653656
Macroautophagy R-HSA-1632852
Gene Silencing by RNA R-HSA-211000
Semaphorin interactions R-HSA-373755
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250
Metabolism of vitamins and cofactors R-HSA-196854
Signaling by ERBB2 ECD mutants R-HSA-9665348
Developmental Biology R-HSA-1266738
Organelle biogenesis and maintenance R-HSA-1852241
Autophagy R-HSA-9612973
Loss of Nlp from mitotic centrosomes R-HSA-380259
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737
Signaling by Rho GTPases R-HSA-194315
Cellular response to heat stress R-HSA-3371556
Influenza Viral RNA Transcription and Replication R-HSA-168273
Infectious disease R-HSA-5663205
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382
eNOS activation R-HSA-203615
G2/M Transition R-HSA-69275
Chaperone Mediated Autophagy R-HSA-9613829
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482
Cell Cycle, Mitotic R-HSA-69278
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249
Selective autophagy R-HSA-9663891
Signaling by ERBB2 R-HSA-1227986
Disease R-HSA-1643685
HSF1 activation R-HSA-3371511
Cellular responses to stimuli R-HSA-8953897
VEGFR2 mediated vascular permeability R-HSA-5218920